Skip to content

Early cardiac rehabilitation after revascularization in patients with acute myocardial infarction: a cohort study

Early cardiac rehabilitation after revascularization in patients with acute myocardial infarction: a cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072425
Enrollment
Unknown
Registered
2023-06-13
Start date
2023-06-22
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myocardial infarction

Interventions

Cardiac rehabilitation group:N/A
Control group:N/A

Sponsors

Daqing Oilfield General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with AMI who were successfully treated and discharged from the Department of Cardiology of Daqing Oilfield General Hospital from April 2015 to March 2017 and met the following criteria: 1) 1) male or female patients = 18 years of age and = 75 years of age; 2) BMI 18-30 kg/m2; 3) stable clinical symptoms for at least 2 weeks; 4) use of angiotensin-converting enzyme inhibitors/angiotensin receptor antagonists/angi angiotensin receptor enkephalinase inhibitors (ACEI/ARB/ARNI), beta-blockers, aldosterone inhibitors, etc., with stable doses of medication for at least 2 weeks; and 5) patients willing to be followed up and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients unable or unwilling to sign informed consent; 2) Patients with a previous history of heart failure disease; 3) Patients with severe liver dysfunction (transaminases more than 3 times the normal reference value); 4) Patients with creatinine > 2.0 mg/dL or end-stage renal disease; 5) Patients with a clear diagnosis of tumor; 6) AMI complicated by surgery, trauma, gastrointestinal bleeding, or PCI; 7) AMI 7) AMI occurred in patients already hospitalized for other reasons; 8) heart transplant patients; 9) patients with a life expectancy of = 24 months; 10) patients who have been included in other clinical studies that affect the results of this study; 11) patients who, in the judgment of the investigator, are not suitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
Mortality from cardiovascular causes;New-onset heart failure;New-onset angina pectoris;Readmission rate for cardiovascular reasons;

Secondary

MeasureTime frame
Medication status;

Countries

China

Contacts

Public ContactFan Zhiqing, Fan Yuxuan

Daqing Oilfield General Hospital

zhiqingfan@126.com+86 138 3676 9588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026